Arcellx (ACLX) Receivables - Other (2023)

Arcellx's (ACLX) quarterly Receivables - Other came in at $2.0 million in Q3 2023, down 75.02% quarter-over-quarter from $8.2 million in Q2 2023.

Arcellx (ACLX) Receivables - Other (2023) Analysis & Trends

Arcellx's Receivables - Other history runs 1 years deep, the most recent figure standing at $2.0 million for Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Arcellx	6.48 Bn	6.48 Bn	-

Download Data